Thursday, July 31, 2008

Tout service picks up OSIP

08:16 EDT OSI Pharma-OSIP: Moving up on ImClone
OSI Pharma's (OSIP) Tarceva is a competitor to ImClone's Erbitux. On news of BMY's offer to buy IMCL, the shares are up +3.08% in the early going. Resistance levels to watch as potential upside objectives are at $52.00, 52.95, $54.00, $54.98, $56.25, $57.13, $59.00. Support is at $50.94 based on current pre-market price. It would be bearish if this level were broken to the downside. :theflyonthewall.com


Boy that was a tough call to make. But if you want a free report on OSIP to make you courageous try this link:
http://www.reveredata.com/reports/store/freereport/mna/4366_7697

4 comments:

  1. This article is created for everyday circumstances, not types that were incredible.
    But I guess that would spoil the item concept. In fact, the only thing that it generally does not have
    is a telephone!

    my blog: download iReb; http://game.ongiroo.mn,

    ReplyDelete
  2. I have been exploring for a little for any high qualioty articles or blog posts
    in this sort of space . Explorinng inn Yahoo I eventually stumbled upon this web site.
    Studying this info So i'm satisfied to show that I've a very excellent uncanny feeling I found out just what I needed.
    I so much certainly will make certaiun to do not omit this website and provides it a look regularly.


    My blog post: LA-Carpet Installation

    ReplyDelete